CMB TECH NV (CMBT.BR) Stock Fundamental Analysis
EBR:CMBT - Euronext Brussels - BE0003816338 - Common Stock - Currency: EUR
CMBT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 61 industry peers in the Oil, Gas & Consumable Fuels industry. CMBT scores excellent on profitability, but there are concerns on its financial health. CMBT has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year CMBT was profitable.
In the past year CMBT had a positive cash flow from operations.
CMBT had positive earnings in 4 of the past 5 years.
CMBT had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
CMBT has a better Return On Assets (12.31%) than 88.52% of its industry peers.
CMBT's Return On Equity of 79.11% is amongst the best of the industry. CMBT outperforms 96.72% of its industry peers.
CMBT has a Return On Invested Capital of 5.06%. This is in the lower half of the industry: CMBT underperforms 68.85% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CMBT is significantly below the industry average of 14.55%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.31% | ||
| ROE | 79.11% | ||
| ROIC | 5.06% |
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)8.95%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of CMBT (72.50%) is better than 98.36% of its industry peers.
In the last couple of years the Profit Margin of CMBT has grown nicely.
Looking at the Operating Margin, with a value of 35.88%, CMBT belongs to the top of the industry, outperforming 80.33% of the companies in the same industry.
CMBT's Operating Margin has improved in the last couple of years.
CMBT's Gross Margin of 58.65% is fine compared to the rest of the industry. CMBT outperforms 67.21% of its industry peers.
CMBT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 35.88% | ||
| PM (TTM) | 72.5% | ||
| GM | 58.65% |
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CMBT is creating some value.
The number of shares outstanding for CMBT has been reduced compared to 1 year ago.
CMBT has less shares outstanding than it did 5 years ago.
CMBT has a worse debt/assets ratio than last year.
2.2 Solvency
CMBT has an Altman-Z score of 0.67. This is a bad value and indicates that CMBT is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CMBT (0.67) is worse than 80.33% of its industry peers.
A Debt/Equity ratio of 3.75 is on the high side and indicates that CMBT has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 3.75, CMBT is doing worse than 93.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.75 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.67 |
ROIC/WACC0.69
WACC7.34%
2.3 Liquidity
CMBT has a Current Ratio of 0.77. This is a bad value and indicates that CMBT is not financially healthy enough and could expect problems in meeting its short term obligations.
CMBT's Current ratio of 0.77 is on the low side compared to the rest of the industry. CMBT is outperformed by 88.52% of its industry peers.
CMBT has a Quick Ratio of 0.77. This is a bad value and indicates that CMBT is not financially healthy enough and could expect problems in meeting its short term obligations.
CMBT's Quick ratio of 0.70 is on the low side compared to the rest of the industry. CMBT is outperformed by 88.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.77 | ||
| Quick Ratio | 0.7 |
3. Growth
3.1 Past
CMBT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -79.01%.
CMBT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 43.41% yearly.
Looking at the last year, CMBT shows a very negative growth in Revenue. The Revenue has decreased by -20.34% in the last year.
The Revenue has been growing slightly by 0.55% on average over the past years.
EPS 1Y (TTM)-79.01%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-100.41%
Revenue 1Y (TTM)-20.34%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%-2.22%
3.2 Future
The Earnings Per Share is expected to decrease by -29.06% on average over the next years. This is quite bad
The Revenue is expected to grow by 9.37% on average over the next years. This is quite good.
EPS Next Y-69.07%
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%
EPS Next 5YN/A
Revenue Next Year7.15%
Revenue Next 2Y15.37%
Revenue Next 3Y9.37%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 7.79, the valuation of CMBT can be described as very cheap.
Based on the Price/Earnings ratio, CMBT is valued a bit cheaper than 78.69% of the companies in the same industry.
CMBT is valuated cheaply when we compare the Price/Earnings ratio to 26.35, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 5.74, the valuation of CMBT can be described as very cheap.
Based on the Price/Forward Earnings ratio, CMBT is valued cheaply inside the industry as 90.16% of the companies are valued more expensively.
CMBT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.19.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.79 | ||
| Fwd PE | 5.74 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CMBT indicates a slightly more expensive valuation: CMBT is more expensive than 75.41% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 10.64 |
4.3 Compensation for Growth
CMBT has a very decent profitability rating, which may justify a higher PE ratio.
CMBT's earnings are expected to decrease with -29.06% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.18
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%
5. Dividend
5.1 Amount
CMBT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EBR:CMBT (6/20/2025, 7:00:00 PM)
8.33
+0.29 (+3.61%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners1.21%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.83B
Analysts80
Price Target11.47 (37.7%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend4.94
Dividend Growth(5Y)116.35%
DP109.72%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-99.31%
Min EPS beat(2)-149.02%
Max EPS beat(2)-49.61%
EPS beat(4)1
Avg EPS beat(4)9.95%
Min EPS beat(4)-149.02%
Max EPS beat(4)242.1%
EPS beat(8)5
Avg EPS beat(8)86.48%
EPS beat(12)8
Avg EPS beat(12)69.92%
EPS beat(16)10
Avg EPS beat(16)53.9%
Revenue beat(2)1
Avg Revenue beat(2)0.7%
Min Revenue beat(2)-9.81%
Max Revenue beat(2)11.21%
Revenue beat(4)3
Avg Revenue beat(4)5.75%
Min Revenue beat(4)-9.81%
Max Revenue beat(4)15.33%
Revenue beat(8)6
Avg Revenue beat(8)28.28%
Revenue beat(12)10
Avg Revenue beat(12)38.19%
Revenue beat(16)14
Avg Revenue beat(16)43.66%
PT rev (1m)-7.42%
PT rev (3m)-15.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-19.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)19.91%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.79 | ||
| Fwd PE | 5.74 | ||
| P/S | 1.51 | ||
| P/FCF | N/A | ||
| P/OCF | 7.84 | ||
| P/B | 1.64 | ||
| P/tB | 1.93 | ||
| EV/EBITDA | 10.64 |
EPS(TTM)1.07
EY12.85%
EPS(NY)1.45
Fwd EY17.43%
FCF(TTM)-3.72
FCFYN/A
OCF(TTM)1.06
OCFY12.76%
SpS5.53
BVpS5.07
TBVpS4.32
PEG (NY)N/A
PEG (5Y)0.18
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.31% | ||
| ROE | 79.11% | ||
| ROCE | 6.75% | ||
| ROIC | 5.06% | ||
| ROICexc | 5.18% | ||
| ROICexgc | 5.31% | ||
| OM | 35.88% | ||
| PM (TTM) | 72.5% | ||
| GM | 58.65% | ||
| FCFM | N/A |
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)8.95%
ROIC(5y)N/A
ROICexc(3y)9.88%
ROICexc(5y)N/A
ROICexgc(3y)9.93%
ROICexgc(5y)N/A
ROCE(3y)11.93%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y15.98%
ROICexc growth 3YN/A
ROICexc growth 5Y15.87%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
F-Score2
Asset Turnover0.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.75 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 7.03 | ||
| Cap/Depr | 666.34% | ||
| Cap/Sales | 86.55% | ||
| Interest Coverage | 3.85 | ||
| Cash Conversion | 39.32% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.77 | ||
| Quick Ratio | 0.7 | ||
| Altman-Z | 0.67 |
F-Score2
WACC7.34%
ROIC/WACC0.69
Cap/Depr(3y)357.13%
Cap/Depr(5y)252.34%
Cap/Sales(3y)69.97%
Cap/Sales(5y)65.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-79.01%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-100.41%
EPS Next Y-69.07%
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%
EPS Next 5YN/A
Revenue 1Y (TTM)-20.34%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%-2.22%
Revenue Next Year7.15%
Revenue Next 2Y15.37%
Revenue Next 3Y9.37%
Revenue Next 5YN/A
EBIT growth 1Y-38.91%
EBIT growth 3YN/A
EBIT growth 5Y15.35%
EBIT Next Year67.95%
EBIT Next 3Y22.95%
EBIT Next 5YN/A
FCF growth 1Y-783.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.61%
OCF growth 3YN/A
OCF growth 5Y11.04%